Mit Holding (MITD) Return on Assets ROA from the third quarter of 2015 to third quarter of 2014 and for the year 2015, Average High and Low, Fundamental Ratios from Sep 30 2015 to Jun 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mit Holding, Inc.  (MITD)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Mit Holding's ROA from the third quarter of 2015 to the third quarter of 2014 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Mit Holding's ROA in the third quarter of 2015?
Mit Holding, Inc. achieved a return on average assets (ROA) of 101.2 % in its third quarter of 2015 a new company high.

Despite the company's net income deteriorating, Mit Holding was able to improve its ROA compared to the second quarter of 2015.

However, within the Healthcare sector 10 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2015 quarter, so far to 90, from total ROA ranking in the second quarter of 2015 at 123.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Jun 30 2014)
II. Quarter
Y / Y Total Assets Change -67.06 % -26.33 % -91.4 % -33.82 % -1.1 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 1 0 0 0 -1
Return On Assets (TTM) 101.2 % 61.89 % 5.51 % -15.01 % -36.9 %
MITD's Total Ranking # 90 # 123 # 1447 # 4812 #
Total Assets (TTM) in million 0 1 0 1 1
Seq. Total Assets Change -59.4 % 49.79 % -21.52 % -30.98 % -9.2 %
Seq. Net Income Change -72.96 % - - - -

MITD's 5 Years Annual ROA >> Back to MITD Management Effectiveness >> Compare MITD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 1
Sector # 11
Overall # 55

Return On Assets Statistics
High Average Low
101.2 %
-77.58 %
-183.65 %
(Sep 30 2015)   (Dec 31 2013)





Financial Statements
Mit Holding's Assets $ 0 million MITD's Balance sheet
Mit Holding's Income $ 0 million Quarterly MITD's Income Statement
MITD's Income by Division See MITD's Income by Division



Annual Return On Assets (Dec 31 2014)
FY 2014		 (Dec 31 2012)
FY 2012		 (Dec 31 2011)
FY 2011
FY
FY
Y / Y Total Assets Change -31.48 % -37.03 % - - -
Total Assets in million 1 1 1 0 0
Y / Y Net Income Change - - - - -
Net Income in million 0 -1 -1 0 0
Annual Return On Assets -36.58 % -125.75 % -92.64 % - -

MITD's 5 Years Annual ROA >> Back to MITD Management Effectiveness >> Compare MITD ROA to its Competitors



More Return On Assets Ratios
MITD's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MITD's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MITD's Competitors
Subscribers only: Roa for Mit Holding's Suppliers
Subscribers only: Return On Assets for MITD's Customers

You may also want to know
MITD's Roi MITD's Inventory Turnover Ratio MITD's Growth Rates MITD's Dividend Comparisons
MITD's Profitability Ratios MITD's Asset Turnover Ratio MITD's Dividend Growth
MITD's Roe MITD's Valuation Ratios MITD's Financial Strength Ratios MITD's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2015, within Healthcare Sector ROA
Valeritas Holdings Inc.  241.97 %
Wearable Health Solutions, Inc.  224.97 %
Rafina Innovations Inc.  146.53 %
Advanced Container Technologies Inc   109.33 %
Mit Holding, Inc.  101.20 %
Relmada Therapeutics Inc  73.33 %
Moderna Inc   72.07 %
Ligand Pharmaceuticals Incorporated  69.60 %
Fennec Pharmaceuticals Inc   66.42 %
Elite Pharmaceuticals Inc   65.11 %
Adm Tronics Unlimited Inc   64.98 %
Cryo cell International Inc   62.85 %
Soleno Therapeutics Inc  60.71 %
Reflect Scientific Inc  53.18 %
Medifirst Solutions, Inc.  51.08 %
Armata Pharmaceuticals Inc   49.63 %
Star Equity Holdings Inc   47.71 %
Lumos Pharma Inc   44.68 %
Viskase Holdings inc   44.09 %
Gilead Sciences Inc   41.48 %
Abiomed Inc   39.29 %
Corbus Pharmaceuticals Holdings Inc   36.36 %
United Therapeutics Corporation  35.76 %
Enanta Pharmaceuticals Inc  35.70 %
Pacific Health Care Organization Inc  33.61 %
Lannett Company Inc  30.59 %
Travere Therapeutics Inc   24.37 %
Biospecifics Technologies Corp  24.17 %
China Biologic Products Holdings Inc   23.11 %
Biogen Inc   21.81 %

Date modified: -0001-11-30T00:00:00+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.